Skip to content

The technical specification of precise drug therapy and the systematic study of novel Coronavirus inactivation procedure for biological samples

The technical specification of precise drug therapy and the systematic study of novel Coronavirus inactivation procedure for biological samples

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037078
Enrollment
Unknown
Registered
2020-08-26
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Accurate treatment of disease

Interventions

case series:Nil

Sponsors

Shanghai First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients on medication.

Exclusion criteria

Exclusion criteria: Negative patient.

Design outcomes

Primary

MeasureTime frame
Treatment effect;

Countries

China

Contacts

Public ContactGuorong Fan

Shanghai First People's Hospital

guorfan@163.com+86 13301777863

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026